The role of beta-catenin in regulating angiogenesis in Wilms tumor.
Ojesina
Akinyemi I
AI
D002471:Cell Transformation, Neoplastic / Q000235:genetics*; D003598:Cytoskeletal Proteins / Q000235:genetics / Q000502:physiology*; D018734:Genes, erbB-2; D006801:Humans; D007680:Kidney Neoplasms / Q000098:blood supply* / Q000209:etiology; D008954:Models, Biological; D009363:Neoplasm Proteins / Q000235:genetics / Q000502:physiology*; D009389:Neovascularization, Pathologic / Q000235:genetics / Q000503:physiopathology*; D018719:Erb-b2 Receptor Tyrosine Kinases / Q000502:physiology*; D015398:Signal Transduction; D015534:Trans-Activators / Q000235:genetics / Q000502:physiology*; D042461:Vascular Endothelial Growth Factor A / Q000096:biosynthesis; D009396:Wilms Tumor / Q000098:blood supply* / Q000209:etiology; D051176:beta Catenin
D003598:Cytoskeletal Proteins; D009363:Neoplasm Proteins; D018719:Erb-b2 Receptor Tyrosine Kinases; D015534:Trans-Activators; D042461:Vascular Endothelial Growth Factor A; D051176:beta Catenin; C495270:CTNNB1 protein, human